Washington, Oct 16 : Researchers from NYU Langone Medical Centre have discovered that specific types of bacteria in the intestine trigger the production of pro-inflammatory immune cells, a finding that can lead to new therapies for inflammatory bowel disease.
In the study conducted using mouse model, the researchers found that
cytophaga-flavobacter-bacteroidetes (CFB) bacteria were associated with the creation of Th17 cells.
The bacteria play a crucial role in digestion and protect against pathogens by outcompeting harmful bacteria.
“It’s not the amount of microbial flora but the kind of microbial flora that seems to count,” said Dr. Dan Littman, NYU School of Medicine.